Background Hepatocellular carcinoma (HCC) frequently relapses after minimally invasive
treatment. This study aimed to observe the influencing factors of different recurrence patterns …

Objective This study aims to determine the risk factors, patterns, and long-term survival
outcomes of late recurrence after radiofrequency ablation (RFA) for hepatocellular …

Background Radiofrequency ablation (RFA) is an effective local ablation therapy for
hepatocellular carcinoma (HCC) with favorable long-term outcome. There is no data on the …

Purpose To determine the risk factors and patterns of recurrence after radiofrequency
ablation (RFA) for hepatocellular carcinoma (HCC) meeting the up-to-seven criteria and to …

Background Despite the high complete necrosis rate of radiofrequency ablation (RFA),
tumor recurrence, either local tumor recurrence or new tumor formation, remains a …

We conducted a retrospective cohort study to investigate the predisposing factors for local
recurrence and complications after percutaneous radiofrequency ablation (RFA) of …

Within 5 years after percutaneous ablation of hepatocellular carcinoma, roughly 70% of
patients experience tumor recurrence. Relapses beyond curative options affected patients' …

Objective To define an optimal cutoff time to distinguish early and late recurrence in
hepatocellular carcinoma (HCC) patients after radiofrequency ablation (RFA), and to …

AIM: To investigate the long-term survival and prognostic factors in hepatocellular carcinoma
(HCC) patients undergoing radiofrequency ablation (RFA) as a first-line treatment …

Objective To determine the survival outcome and prognostic factors of hepatocellular
carcinoma (HCC) survival in patients who underwent radiofrequency ablation (RFA) …